Whitehawk Therapeutics (WHWK) Change in Receivables (2016 - 2025)
Whitehawk Therapeutics' (WHWK) quarterly Change in Receivables came in at $1.0 million in Q1 2025, up 280.18% year-on-year from $263033.2 in Q1 2024, and up 256.99% on a QoQ basis from -$637000.0 in Q4 2024.
Whitehawk Therapeutics (WHWK) Change in Receivables (2016 - 2025) Analysis & Trends
Whitehawk Therapeutics (WHWK) has 8 years of Change in Receivables data on file, last reported at $1.0 million in Q1 2025.
- On a quarterly basis, Change in Receivables rose 280.18% year-over-year to $1.0 million in Q1 2025; TTM through Dec 2025 was $1.0 million, a 140.96% increase from a year earlier, with the FY2025 full-year figure at $1.0 million, up 140.96% from the prior year.
- Change in Receivables for Q1 2025 stood at $1.0 million, up from -$637000.0 in the prior quarter.
- Over the last five years, Change in Receivables for WHWK reached as high as $3.7 million in Q1 2023 and fell as low as -$14.0 million in Q1 2021.
- Historically, Change in Receivables has averaged -$483066.7 across 5 years, with a median of -$120000.0 in 2021.
- Across the five-year window, Change in Receivables sank 437.5% in 2022 and surged 930.81% in 2023, its largest moves.
- Year by year, Change in Receivables stood at -$120000.0 in 2021, then tumbled by 232.5% to -$399000.0 in 2022, then jumped by 42.61% to -$229000.0 in 2023, then tumbled by 178.17% to -$637000.0 in 2024, then surged by 256.99% to $1.0 million in 2025.
- Per Business Quant data, the three most recent Change in Receivables figures were $1.0 million in Q1 2025, -$637000.0 in Q4 2024, and $620000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 75.30 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.84 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Whitehawk Therapeutics | 34.18 Mn | 34.18 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 1.00 Mn |
| Mar 31, 2025 | 1.00 Mn |
| Dec 31, 2024 | -637,000.00 |
| Dec 31, 2024 | -637,000.00 |
| Sep 30, 2024 | 620,000.00 |
| Sep 30, 2024 | 620,000.00 |
| Jun 30, 2024 | 987,000.00 |
| Jun 30, 2024 | 987,000.00 |
| Mar 31, 2024 | -555,000.00 |
| Mar 31, 2024 | -555,000.00 |
| Dec 31, 2023 | -229,000.00 |
| Dec 31, 2023 | -229,000.00 |
| Sep 30, 2023 | 2.04 Mn |
| Sep 30, 2023 | 2.04 Mn |
| Jun 30, 2023 | -1.89 Mn |
| Jun 30, 2023 | -1.89 Mn |
| Mar 31, 2023 | 3.70 Mn |
| Mar 31, 2023 | 3.70 Mn |
| Dec 31, 2022 | -399,000.00 |
| Dec 31, 2022 | -399,000.00 |